Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation.
Li HuangXiaoting ZhongAn LiFuping TuMiao HeXueming XuXiaohui LiuXiaoli ZengJun ChiTian TianChunli WangXiangcai WangJianming YePublished in: Cancer cell international (2024)
This study provided a novel concept that STX6 exerted oncogenic effects by activating the STAT3 signaling pathway, and STX6 might be a promising therapeutic target for HCC.